Tag: Cancer: Leukemia
Increased Cost of CLL Tx Poses Considerable Financial Burden
Number of patients living with CLL projected to increase 55% by 2025; costs set to rise 590%
Immunotherapy Promising for Tx of Acute Myeloid Leukemia
In preliminary trial, four of nine patients with acute myeloid leukemia had complete remission
Adding Rituximab to Chemo Ups Event-Free Survival in ALL
Findings in young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia
Pregnancy Screens Lacking for Teens With Leukemia
Low rates for teens with acute leukemia and ER visits before teratogenic exposures
Treating Leukemia With Cord-Blood Transplant Looks Promising
Donors and recipients don't need to be a perfect match, researcher says
Venetoclax Monotherapy Active in AML With Adverse Features
Overall response rate 19%; additional 19% have antileukemic activity without meeting IWG criteria
Nilotinib Shows Early Promise for Parkinson’s Disease
Medication generally found safe, and study findings hint at a benefit
HSCT No Better Than Chemo in Philadelphia-Negative ALL
For patients ≥40 years, HSCT linked to lower cumulative incidence of remission, worse mortality
Microbiome Linked to Infectious Complications in AML
Gastrointestinal microbiome diversity linked to infections for patients undergoing induction chemo
Radon in the Home Linked to Hematologic Malignancies
Association seen in women, but no connection found in men
